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ABSTRACT
The most frequent cause of acute kidney injury (AKI) is ischemia reperfusion  injuries 
that causes inflammation. Furosemide is still used in AKI’s therapy. The advantages and 
disadvantages of furosemide in AKI remain controversial. The aim of the study was to 
investigate the effect of furosemide on kidney damage in AKI rat models. Twenty-five 
male (2-3 months old) Sprague-Dawley rats were divided into 5 groups; sham operation 
(SO, n=5), ischemic-reperfusion (IR, n=5), IR+furosemide 3.6 mg/kgBW (IR+F1, 
n=5), IR+furosemide 7.2 mg/kgBW (IR+F2, n=5), and IR+furosemide 14.4 mg/kgBW 
(IR+F3, n=5). Abdominal surgery was performed under ketamine anesthesia to produce 
ischemic reperfusion (IR) by mean of renal artery clamping for 45 min. Urine output, 
serum creatinine level, tubular injury score, and TLR4 gene expression were examined 
to investigate kidney damage. Periodic acid-schiff (PAS) staining was measured to 
examine kidney tubular injury. Data were analyzed using One-Way ANOVA and Kruskal-
Wallis test with significance level of p<0.05. AKI rat models which were given 3.6 and 
7.2 mg/kgBW of furosemide (0.014±0.001 mL/min; and 0.012±0.007) showed higher 
(p>0.05) creatinine clearance compared to IR (0.009±0.003) while administration of 14.4 
mg/kgBW furosemide (0.009±0.004) denoted equal creatinine clearance to IR (p>0,05). 
Kidney tubular injury score of 3.6 mg/kgBW furosemide (2.89±0.13) was lower (p>0.05) 
than IR (3.26±0.19) whereas 7.2 mg/kgBW and 14.4 mg/kgBW furosemide (3.55±0.26; 
3.83±0.19) were higher (p<0.05) than IR. Administration of 3.6 mg/kgBW furosemide 
(0.99±0.08) indicated lower (p<0.05) TLR4 gene expression than IR (1.20±0.08) whilst 
7.2 mg/kgBW furosemide (1.23±0.13) was not-significantly higher (p>0.05) and 14.4 mg/
kgBW furosemide (1.63±0.12) was significantly higher (p<0.05) than IR. In conclusion, 
administration of 3.6 mg/kgBW furosemide reduces kidney damage in AKI rat models 
while higher dosages (7.2 mg/kgBW and 14.4 mg/kgBW) increase kidney damage. 
ABSTRAK
Penyebab acute kidney injury (AKI) yang paling sering adalah cedera iskemia-reperfusi 
sehingga menyebabkan timbulnya inflamasi. Pada penatalaksanaan AKI masih banyak 
digunakan furosemid. Keuntungan serta kerugian penggunaan furosemid pada AKI masih 
menjadi kontroversi. Penelitian ini bertujuan untuk mengetahui pengaruh pemberian 
furosemid terhadap kerusakan ginjal pada model tikus AKI. Sebanyak 25 ekor tikus 
jantan umur 2-3 bulan galur Sprague Dawley dikelompokkan menjadi 5 kelompok, yaitu 
Sham Operation (SO, n=5), Ischemia reperfusion (IR, n=5), IR+furosemid 3,6 mg/kgBB 
(IR+F1, n=5), IR+furosemid 7,2 mg/kgBB (IR+F2, n=5), dan IR+furosemid 14,4 mg/kgBB 
(IR+F3, n=5). Luaran urin, kadar kreatinin serum, skor cedera tubulus, dan ekspresi 
gen TLR4 diperiksa untuk mengetahui adanya kerusakan ginjal. Dilakukan pewarnaan 
Periodic Acid-Schiff (PAS) pada sediaan histopatologi untuk menilai skor cedera tubulus 
240
J Med Sci, Volume 50, No. 3, 2018 July:  239-248
ginjal. Data dianalisis dengan One Way ANOVA dan Kruskal Wallis (p<0,05). Creatinine 
clearance pada model tikus AKI yang diberi furosemid dosis 3,6 mg/kgBB (0,014±0,001 
mL/min) dan dosis 7,2 mg/kgBB (0,012±0,007) lebih tinggi dari IR (0,009±0,003) 
(p>0,05), sedangkan dosis 14,4 mg/kgBB (009±0,004) sama dengan IR (p>0,05). Skor 
cedera tubulus ginjal pada model tikus AKI yang diberi furosemid dosis 3,6 mg/kgBB 
(2,89±0,13) lebih rendah dari IR (3,26±0,19) (p<0,05), sedangkan dosis 7,2 mg/kgBB 
(3,55±0,26) dan 14,4 mg/kgBB (3,83±0,19) lebih tinggi dari IR (p<0,05). Ekspresi gen 
TLR4 pada model tikus AKI yang diberi furosemid dosis 3,6 mg/kgBB (0,99±0,08) lebih 
rendah dari IR (1,20±0,08) (p<0,05), sedangkan dosis 7,2 mg/kgBB (1,23±0,13) lebih 
tinggi dari IR (p>0,05), dan dosis 14,4 mg/kgBB (1,63±0,12) mg/kgBB juga lebih tinggi 
dari IR (p<0,05). Dapat disimpulkan, pemberian furosemid dosis 3,6 mg/kgBB dapat 
memperbaiki kerusakan ginjal pada model tikus AKI, sedangkan pada dosis lebih besar 
(7,2 mg/kgBB dan 14,4 mg/kgBB) memperburuk kerusakan ginjal pada model tikus AKI. 
Keywords: acute kidney injury - ischemic-reperfusion – furosemide – creatinine – kid-
ney tubular injury
INTRODUCTION
Acute kidney injury (AKI) is a health 
problem due to increasing the incidence of 
AKI in both the developed and developing 
countries that increase mortality rate.1–5 
About 20% of AKI may progress to 
chronic kidney disease thereby increase the 
maintenance costs.6,7 The use of furosemide in 
the treatment of AKI remains controversies. 
Furosemide improves GFR in patients with 
portal hypertension and ascites, as well 
as lower hyperkalemia, hyperchloremia, 
acidosis, and fluid overload on patien who 
are at risk of AKI.8  Nonetheless, furosemide 
increase serum creatinine in cardiac surgery.9 
Furosemide is more effective than mannitol 
when given along with hydration fluids to 
prevent nephrotoxicity due cisplatin10,11 
but furosemide increase mortality in AKI 
patients with critical illness.12 Furosemide 
in preclinical studies was known to decrease 
apoptosis and related gene expression in 
the IRI mouse model.13 Inflammation is the 
main mechanism of AKI due to ischemia.14 
Toll-like receptor4 (TLR4) activation is the 
major pathway of the innate imune response 
that started the kidney injury.15 The study 
was conducted to investigate the effects of 




Twenty-five Sprague-Dawley male 
2-3 months old rats were used in the quasi- 
experimental study with post test only 
controlled group design. The rats were 
divided into 5 groups; sham operation 
(SO, n=5), ischemic-reperfusion (IR, n=5), 
IR+furosemide 3.6 mg/kgBW (IR+F1, n=5), 
IR+furosemide 7.2 mg/kgBW (body weight) 
(IR+F2, n=5), IR+furosemid 14.4 mg/kgBW 
(IR+F3, n=5). The sham operation used as 
control, and ischemic-reperfusion as AKI 
model.16 Wheres in the group IR+F1, IR+F2, 
IR+F3 given furosemide 3.6, 7.2, 14.4 mg/
BW, respectively, once giving after surgery. 
Determination of the dosage of furosemide 
according to Sinto and Nainggolan17 which 
says that administration of furosemide can 
be useful in the first 12 h, and initially can be 
given intravenous furosemide bolus 40 mg. 
If the benefit is not visible the dosage can be 
doubled to 100-250 mg/times in 1-6 h rapidly 
or 10-20 mg/kgBW/d slowly with a maximum 
dose of 1 g/d. All animals terminated on 
day 3. All experimental procedures were 
conducted according to the Medical and 
Health Research Ethics Committee, Faculty 
of Medicine, Public Health and Nursing, 
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Universitas Gadjah Mada, Yogyakarta. The 
ischemia-reperfusion injury model was 
performed under ketamine anesthesia 100 
mg/kgBW. The AKI was induced by mean 
of clamping both renal pedicle using non-
traumatic vascular clamp (Hammacher®) 
for 45 min. Then, both clamps were released 
and followed by reperfusion. The incision 
site closed using silk surgical thread 3/0 (One 
Med®). Blood serum was obtained from the 
retroorbital vein for creatinine measurement. 
Measurement of tubular injury
Tubular injury score measurement was 
done by mean of Periodic Acid-Schiff (PAS) 
staining, examined with a light microscope 
(Olympus CX22®) and portraited with Op-
tilab software with 400x magnification at 
the corticomedullary junction area as many 
as 15 fields per kidney. Scoring divided into 
4 category, they were: 0-4 (0=normal; 1=tu-
bular injury <25%; 2=tubular injury involve 
25-50%; 3=tubular injury involve 50-75%; 
4=tubular injury involve >75%). The assess-
ment included renal tubular dilatation, loss 
of brush border of proximal tubules, deple-
tion of the tubular epithelial cell and the ac-
cumulation of intraluminal cast. 
Gen expression examination
Examination of TLR4 gene expression 
used RT-PCR. Total RNA was extracted us-
ing RNA Isoplus, followed by quantifica-
tion of RNA concentration using sphectro-
photometry. cDNA was made using Rever 
TraAce® (Toyobo, Japan, Cat.No.TRT-101) 
and random primer (Toyobo, Japan, Cat.No 
3801), with PCR condition: 30oC for 10 min 
(denaturation), 42oC for 60 min (annealing), 
99oC for 5 min (extension). Reverse tran-
scriptase PCR was carried out to amplify the 
following specific cDNAs: forward rTLR4: 
5’ -CAGGGAGCACGAGGCTTCTA-
ACC-3’, and reverse: 5’-CTTGTGCCCT-
GTGAGGTCGTTGA-3’). PCR conditions: 
94°C for 2 s (initial denaturation), 94°C for 
10 s (denaturation), 60°C for 30 s (annealing) 
and 72°C for 1 min (extension) and 72°C for 
10 min (last extension). The gene expression 
was quantified using ImageJ software. GAP-
DH was used as housekeeping gene.
Statistical analysis  
Data were analyzed using Shapiro-Wilk 
test for normality and Levene test for homo-
geneity. Urine output, creatinine urine lev-
el, creatinine clearance, tubular injury score 
were analized by one-way ANOVA and fol-
lowed by pos hoc LSD test. Creatinine se-
rum level was analized by Kruskal Wallis 
test and followed by pos hoc Mann-Whitney 
test. A p<0.05 was used to determined the 
level of significance.  
RESULTS
Significantly difference in urine output 
between the SO group (7.8±1.79 mL) and IR 
group (15.00±3.08) on day 3 after surgery 
but non-significantly difference between IR 
group (15.00±3.08) and the treatment groups 
IR+F1 (10.30±4.66), IR+F2 (14.2±4.92), 
IR+F3 (14.40±2.41) were observed. Serum 
creatinine level of IR group [1.23 mg/dL 
(1.10-1.66)] was significantly lower than 
IR+F3 group [3.53 (3.01-4.71)] (p<0,05) and 
non-significantly higher than IR+F1 [0.76 
(0.68-1.81)] (p=0.151) and IR+F2 [1.19 
(1.09-3.01)] groups (p=0.841). The urinary 
creatinine level of IR group (0.98±0.15) was 
significantly lower than IR+F2 (2.16±1.31) 
(p=0.049) and IR+F3 (3.18±0.61) (p=0.001) 
groups but non-significantly higher than 
IR+F1 group (1.76±1.18) (p=0.179). There 
was non-significantly higher in creatinine 
clearance of IR+F1 (0.014±0.001) and 
IR+F2 (0.012±0.007) compare to IR group 
(0.009±0.003) and equal to IR+F3 group 
(0.009±0.004) (p>0.005).
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The kidney tubular injury score of IR 
group (3.26±0.19) was significantly higher 
than IR+F1 group (2.89±0.13) (p=0.005) but 
significantly lower than IR+F2 (3.55±0.26) 
(p=0.024) and IR+F3 (3.83±0.19) (p=0.000) 
groups. Significantly lower in TLR4 gene 
expression of IR group (1.20±0.08) than 
IR+F1 group (0.99±0.08) (p=0.002) but non-
significantly higher than IR+F2 (1.23±0.13) 
(p=0.680) and significantly higher than 
IR+F3 (1.63±0.12) (p=0.000) groups were 
reported. 
FIGURE 1. The effect of furosemide on serum creatinine level (A), urine output 24 hours 
(B), urine creatinine level (C), and creatinine clearance (D). * = p<0,05 vs SO, # 
=p<0,05 vs IR. SO (Sham Operation), IR (Ischemia-reperfusion), IR+F1 (Ischemia-
reperfusion+furosemide 3.6 mg/kgBW, IR+F2 (Ischemia-reperfusion+furosemide 
7.2 mg/kgBW), IR+F3 (Ischemia-reperfusion+furosemide 14.4 mg/kgBW).
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DISCUSSION
The volume of urine output in the IR 
group is higher than the SO group. This 
result similar with Younan et al.18 study, 
that in mice IR group had higher urine 
volume at 24 and 48 h after reperfusion 
compared with SO. Ischemia-reperfusion 
causes damage primarily in the proximal 
tubule S3 segment and the thick ascending 
loop of Henle. Ischemia causes the cord 
region becomes increasingly diminished 
oxygenation, causing severe damage. Due 
to damage involving the proximal tubules, 
the renal function related to the formation 
of urine is impaired, especially reabsorption. 
If this reabsorption function is impaired 
by tubular cells damage, then only a little 
water can be reabsorbed, and most will be 
excreted. In the IR group that were given 
furosemide had urine volume higher than the 
FIGURE 2. Renal histological picture on day 3 with PAS staining and tubular injury score (A). 
TLR4/GAPDH gene expression (B). * = p<0,05 vs SO, # =p<0,05 vs IR. SO (Sham 
Operation), IR (Ischemia-reperfusion), IR+F1 (Ischemia-reperfusion+furosemide 
3.6 mg/kgBW, IR+F2 (Ischemia-reperfusion+furosemide 7.2 mg/kgBW), IR+F3 
(Ischemia-reperfusion+furosemide 14.4 mg/kgBW). Black arrows showed brush 
border. Yellow arrows showed intraluminal cast. Yellow circle showed tubular dil-
atation.
244
J Med Sci, Volume 50, No. 3, 2018 July:  239-248
SO group but lower than the IR group. The 
volume of urine was higher with the higher 
dose of furosemide. The timing of giving 
furosemide may affect the process of kidney 
damage both the functional and structural. 
Furosemide guard against partial damage 
shown by the improvement of the medullary 
hypoxia during the AKI, the impact is in 
the early phase after the occurrence of AKI 
than ongoing AKI. However the greater the 
dose of furosemide given, the more the urine 
volume.19
Creatinine serum level in IR group was 
1.23 (1.10-1.66) higher compared to that of 
SO group 0.74 (0.48-0.91). As explained by 
Wu et al.20 and Younan et al.18, there were 
creatinine level increase in IRI group. In 
normal condition, creatinine is filtered by 
glomerulus but not absorbed. About 10-20% 
creatinine is excreted to proximal tubules. 
Thus, any damage in tubules will affect the 
process. Consequently, the creatinine serum 
level becomes higher. Creatinine serum level 
in IR group receiving furosemide increased 
as furosemide dose increase. This is possibly 
because at the time of ischemia occurs ATP 
depletion, and when there is furosemide as a 
ligand which binds to the transporter as a site 
of action, the ATP should be used for repairs 
but used to work, and the greater number of 
ligand binding, ATP getting a much needed 
so that the kidney getting damaged because 
the heavier work. In contrast, Lassnigg et 
al.9 study demonstrated creatinine serum 
level increase in cardiac surgery. The 
negative effect of furosemide probably due 
to neurohormonal activation dan temporary 
blood pressure increase as the result of 
sympathetic neural activation dan renin 
angiotensin system. Those mechanisms 
might increase peripheral vascular resistance, 
left ventricle afterload, heart workload, and 
cardiac output reduction. Thus, they might 
worsen myocardial ischemia. Moreover, 
renal blood flow maldistribution induction 
through medular perfusion diversion due 
to cortex vascular resistance decline might 
promote tubular disfunction.9
Urine creatinine level was elevated 
in SO group (5.25±0.69) and depleted in 
IR group (0.98±0.15). In physiological 
condition, creatinine was filtrated by the 
glomerulus and excreted through urine 
hence, the creatinine level was elevated in 
urine dan depleted in serum and if there is 
any damage causing low creatinine level in 
urine. Urine creatinine level in IR+F1 was 
higher compared to that of IR group (IR+F1 
vs IR (1.76±1.18 vs 0.98±0.15). The greater 
furosemide dose given the higher urine 
creatinine level (IR+F1(1.76±1.18), IR+F2 
(2.16±1.31), dan IR+F3 (3.18±0.61)). This 
condition contradicted with serum creatinine 
level in this study that demonstrated serum 
creatinine raise as furosemide dose increase.
Creatinine is catabolism yield of muscle 
creatinine and distributed to entire body 
fluid. Mostly, creatinine is excreted by the 
kidney. Creatinine has low molecular weight 
(113D) that facilitate its simple movement 
through glomerular filtration barrier into 
tubular filtrate. Creatinine is not reabsorbed 
nor affected by urine flow.21 About 10-20% 
creatinine is secreted into proximal tubules. 
Active secretion done by tubular cells is 
facilitated by that are OAT1 (organic anion 
transporter), OAT2, OAT3, OAT4, OCT1 
(organic cation transporter), OCT2, OCT3, 
OCTN1 (organic cation transporter novel), 
OCTN2, MATE1 and MATE2-K.22–24 
Correspondingly, furosemide requires the 
transporter to reach its target that are OAT1, 
OAT2, OAT3, and OAT4.25–27 Kim et al.26 
demonstrated OAT1 elevation in rat renal 
after 7 days furosemide administration. and 
the rise of OAT1 and OAT3 expression in IR 
model.28 There is some similar transporter 
that involved in creatinine and furosemide 
secretion. The possible explanation of higher 
urine creatinine level in higher furosemide 
dose is due to higher serum creatinine level 
in IR group receiving furosemide hence, the 
excreted creatinine in urine is greater. 
Creatinine clearance in the SO group 
was higher than the IR group and differently 
significant (p<0.05), it shows that the function 
of renal excretion in the SO group is better 
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than the IR group and vice versa. Creatinine 
clearance in the IR+F1 and IR+F2 groups 
were higher than IR group, and IR+F3 equal 
to IR group (p>0.05). In accordance with 
Heyman et al.29 that creatinine clearance in 
the group of acute renal failure (ARF) that 
were given furosemide were higher than the 
ARF group on the first day (p<0.05), and had 
a tendency to rise on the 3rd day but was not 
significant (p>0.05). Creatinine clearance 
describes the renal excretory function and 
can be used to predict GFR. The greater the 
creatinine clearance value showed the better 
kidney functions, and vice versa. In this 
study of kidney function in the group which 
were given the common dose of furosemide 
was better than that the group which did not 
receive furosemide, and the group which was 
given higher doses of furosemide had worse 
kidney function than the group that did not 
receive furosemide. In contrast to Lassnigg 
et al.9 that administration of furosemide 
in cardiac surgery showed creatinine 
clearance lower than for the placebo group. 
It is associated with the activation of 
neurohumoral, increased blood pressure as 
a result of the activation of the sympathetic 
and the renin-angiotensin system. 
The tubular injury is characterized 
by tubular dilatation, brush border loss, 
depletion of epithelial cell and intraluminal 
cast,30 so that it causing kidney morphology 
changes.31 Epithelial cell injury due to 
ischemic-reperfusion especially in the S3 
segment of proximal tubules.20 Our study 
showed that increasing of tubular injury score 
was in-line with increasing of furosemide 
dose. Heyman et al.32 show that furosemide 
decreased structural and functional of tubular 
injury in S3, especially in the middle and the 
outer zone of the inner stripe of outer medulla 
kidney that has isolated and perfused. The 
decline in structural damage assessed from 
the decrease fragmentation in S3 tubules. The 
protective effect of furosemide in the kidney 
was correlated with of active reabsorption 
and reduced of oxygen required by the mTAL 
cells with limited oxygen supply. Loop 
diuretics increase the oxidation potential 
of cytochrome oxidase in whole perfused 
kidney and increases oxygen pressure in 
the outer medulla of kidney. It is showed 
protective effects toward the proximal tubule 
in-line with research Heyman et al.32 Several 
clinical studies in-line with the results of 
this study, Cantarovich et al.19 showed that 
high doses of furosemide can maintain urine 
output but has no effect on median survival 
and kidney repair in patients with AKI. It 
was showed by the improvement of medulla 
hypoxia during AKI. The impact may be 
more significant in the initial phase of the 
AKI than after AKI.19 Furosemide has a 
weak inhibitor carbonic anhydrase enzyme 
impact.33 Carbonic anhydrase enzymes play 
a role in the reaction between CO2 and H2O 
into H+ and HCO3
-. Hydrogen ions that are 
secreted into the lumen of the kidney tubules 
to replace reabsorbed Na+. The hydrogen 
ions in the luminal kidney tubules react 
with HCO3
- to form H2CO3. Hydrogen ions 
also react with the NH3
- to form NH4. If the 
carbonic anhydrase enzyme is inhibited, H+ 
will not be secreted into the tubular lumen. 
Therefore NH3
- will not be neutralized to 
NH4, so NH3
- will damage kidney.34
TLR4 is a pattern recognition molecule 
doe to ischemic injury. Ischemic caused 
tubular and microvascular injuries, thus the 
integrity of cytoskeleton and cell polarity 
will be lost, brush border of proximal 
tubules loss, loss of polarity followed by the 
change of the adhesion molecules location 
and other membrane proteins such as Na+K+-
ATPase and β-integrin.35 The microvascular 
injury causes the disruption of blood 
flow, increased of leukocyte adhesion and 
increased of blood vessels permeability 
that causes a response inflammation.36 
Activation and epithelial damage led to the 
formation of inflammatory and vasoactive 
mediators, which provide feedback on the 
vasoconstriction and inflammation blood 
vessel. Furthermore, activation of innate 
immune system plays an important role in 
the initiation of acute injuries and acute on 
chronic.14 Ischemic-reperfusion injury causes 
the activation of the innate immune system. 
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Activation of the innate immune system 
begins to bond TLR by endogenous ligands. 
The TLR4 has expressed by the kidney is a 
potential mediator of innate immune system 
activation and inflammation. Appropriate 
research Wu et al.15 TLR4 gene expression 
in the kidney increased after ischemic, 
mainly expressed by cells tubulus. In this 
study, TLR4 gene expression was higher in 
IR group than SO group. TLR4 mediates the 
expression of pro-inflammatory cytokines 
and chemokines in the kidney during an IRI. 
There are two mechanisms that signaling 
pathway in TLR4: MyD88-dependent and 
MyD88-independent, until the process of 
transcription. In this study, IR+F3 has the 
highest TLR4/GAPDH among others. Group 
IR+F3 has the highest score of ischemic 
injury score in-line with the most severe 
inflammation. To determine the role of renal 
tubular epithelial cells in the inflammatory 
process may need to do further research on 
markers of epithelial cell damage in the renal 
tubules.
The results of this study were AKI rat 
models which were given 3.6 mg/kgBW and 
7.2 mg/kgBW of furosemide (0.014±0.001 
and 0.012±0.007 mL/min) showed higher 
creatinine clearance compared to IR 
(0.009±0.003) (p>0.05) while administration 
of 14.4 mg/kgBW furosemide (0.009±0.004) 
indicated equal creatinine clearance to IR 
(p>0.05). Kidney tubular injury score of 
3.6 mg/kgBW furosemide (2.89±0.13) was 
lower than IR (3.26±0.19) (p<0.05) while 7.2 
mg/kgBW and 14.4 mg/kgBW furosemide 
(3.55±0.26; 3.83±0.19) were higher than IR 
(p<0.05). Giving of 3.6 mg/kgBW furosemide 
(0.99±0.08) showed lower TLR4 gene 
expression than IR (1.20±0.08) (p<0.05) 
whereas 7.2 mg/kgBW furosemide (1.23±0.13) 
was non-significantly higher (p>0.05) and 
14.4 mg/kgBW furosemide (1.63±0.12) was 
significantly higher than IR (p<0.05). 
CONCLUSION
Administration of 3.6 mg/kgBW furosemide 
reduces kidney damage in AKI rat models while 
higher dosages (7.2 mg/kgBW and 14.4 mg/
kgBW) increase kidney damage in the used 
models. It shows that administration of 40 mg 
furosemide in the early phase of human AKI 
reduces kidney damage, but not to be increased 
of the dosage.
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